statistiche ricercatore

Continente	#
NA - Nord America	1.037
AS - Asia	876
EU - Europa	581
SA - Sud America	222
Continente sconosciuto - Info sul continente non disponibili	22
AF - Africa	9
OC - Oceania	2
Totale	2.749

Nazione	#
US - Stati Uniti d'America	952
SG - Singapore	310
IT - Italia	208
CN - Cina	207
BR - Brasile	163
RU - Federazione Russa	142
VN - Vietnam	123
BD - Bangladesh	69
HK - Hong Kong	47
CA - Canada	42
DE - Germania	39
FR - Francia	34
GB - Regno Unito	33
IN - India	32
FI - Finlandia	28
SE - Svezia	21
ID - Indonesia	18
MX - Messico	18
AR - Argentina	17
PL - Polonia	17
TR - Turchia	17
EC - Ecuador	15
NL - Olanda	12
IQ - Iraq	10
AT - Austria	9
CO - Colombia	7
ES - Italia	7
PE - Perù	6
PK - Pakistan	6
VE - Venezuela	6
CR - Costa Rica	5
JP - Giappone	5
CH - Svizzera	4
GT - Guatemala	4
IL - Israele	4
LT - Lituania	4
MY - Malesia	4
PY - Paraguay	4
UA - Ucraina	4
UZ - Uzbekistan	4
CL - Cile	3
JM - Giamaica	3
JO - Giordania	3
KZ - Kazakistan	3
SI - Slovenia	3
SV - El Salvador	3
BY - Bielorussia	2
CI - Costa d'Avorio	2
CW - ???statistics.table.value.countryCode.CW???	2
DO - Repubblica Dominicana	2
GR - Grecia	2
KE - Kenya	2
NI - Nicaragua	2
NO - Norvegia	2
PR - Porto Rico	2
RO - Romania	2
TH - Thailandia	2
TT - Trinidad e Tobago	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BB - Barbados	1
BE - Belgio	1
BO - Bolivia	1
CG - Congo	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
GE - Georgia	1
HN - Honduras	1
IE - Irlanda	1
LB - Libano	1
LV - Lettonia	1
MA - Marocco	1
NC - Nuova Caledonia	1
NP - Nepal	1
OM - Oman	1
PH - Filippine	1
PS - Palestinian Territory	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TW - Taiwan	1
ZA - Sudafrica	1
Totale	2.729

Nome	#
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis	337
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study	287
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	259
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome	238
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	236
Tissue Characterization in Cardiac Amyloidosis	230
Positron emission tomography in cardiac amyloidosis: current evidence and future directions	224
PET and Cardiac Amyloidosis	218
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	217
Automated Neural Architecture Search for Cardiac Amyloidosis Classification from [18F]-Florbetaben PET Images	204
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	187
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	58
Dogmas and heresies in coronary blood flow regulation	54
Totale	2.749

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2023/2024	24	0	0	4	4	0	3	2	1	0	0	0	10
2024/2025	445	8	14	28	4	20	18	53	73	31	16	71	109
2025/2026	1.980	135	262	197	290	185	137	140	101	167	122	133	111
2026/2027	300	41	49	117	93	0	0	0	0	0	0	0	0
Totale													2.749